Exabis Library
Welcome to the e-CCO Library!
P327: Evolution after a “de-intensification” strategy with anti-TNF therapy in patients with inflammatory bowel disease in clinical remission: multicenter study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P327: Long-term effectiveness of ustekinumab in refractory Crohn's disease: an Italian multicenter real-life study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P327: Segmental colectomy for ulcerative colitis: a new paradigm? A multi-centric study in 72 patients
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P327: Symptom relevance attributed by inflammatory bowel disease patients has a differential impact on their quality of life
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P328 Faecal microbiota transplantation as treatment for recurrent Clostridiodes difficile infection in patients with inflammatory bowel disease: Experiences of the Netherlands donor faeces bank
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P328: Crohn’s colitis care (CCCare): development and testing of a bespoke cloud-based clinical management system for inflammatory bowel disease (IBD)
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P328: Factors related to short- and long-term treatment results and usefulness of infliximab for refractory ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P328: Holistic well-being as Patient-reported outcomes (PROs) in translational IBD research: Prospective capture of CUCQ32 as study endpoints for mechanistic biomarker MUSIC/GIDAMPs study.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P328: In silico evaluation and pre-clinical efficacy of anti-TNF and anti-IL-23 combination therapy in Inflammatory Bowel Disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P328: Low vitamin K, vitamin D and calcium dietary intake in IBD patients represents a potentially reversible risk factor for osteoporosis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P328: Patient and physician perspectives on managing iron deficiency with or without anaemia in inflammatory bowel disease: findings from a European online survey
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P328: Ustekinumab is an effective and safe therapy in anti-TNF refractory Crohn’s Disease: a two year real-life observational study from Spain
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P329 ECCO grant recipient: preliminary results of the HOT-TOPIC trial (Hyperbaric Oxygen Therapy for the Treatment Of Perianal fistulas In Crohn’s disease)
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P329: Adalimumab therapeutic drug monitoring test validated for measuring ABP 501 biosimilar
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P329: Comparative Assessment of Adalimumab Trough Levels between Point-of-Care Testing and current Standard of Care (enzyme linked immunosorbent assay) in patients with Inflammatory Bowel Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P329: Effect of adalimumab dose escalation on clinical, health-related quality of life, treatment satisfaction and work productivity outcomes among patients with ulcerative colitis in a clinical practice setting: results from INSPIRADA
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P329: Infliximab biosimilar in the treatment of inflammatory bowel disease: a Japanese single-cohort observational study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P329: Stool multiplex molecular PCR assay in comparison to conventional stool tests for detecting gastrointestinal infections as cause of flares in Inflammatory Bowel Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P329: Utility of faecal calprotectin to assess Crohn’s disease activity in patients with an ileostomy
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P329: Which should come first? Surgery or biologic therapy for ileocaecal Crohn’s disease in biologic naïve patients
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM